Kalaris Therapeutics Inc

NASDAQ: KLRS · Real-Time Price · USD
2.46
0.19 (8.37%)
At close: Aug 15, 2025, 3:55 PM
2.42
-1.43%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kalaris Therapeutics Inc Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q1 2024 Q4 2023
Period Ending Mar 31, 2025 Mar 31, 2024 Dec 31, 2023
Net Income
-10.2M -3.41M -3.47M
Depreciation & Amortization
n/a n/a n/a
Stock-Based Compensation
374K 31K 31K
Other Working Capital
1.41M -841K -1.31M
Other Non-Cash Items
35K 931K 105K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
2.35M -2.08M -801K
Operating Cash Flow
-7.44M -4.52M -4.14M
Capital Expenditures
n/a n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
n/a n/a n/a
Debt Repayment
7.5M 4.99M n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
99.77M -5K 117K
Financial Cash Flow
107.27M 6.58M 6.86M
Net Cash Flow
99.83M 2.06M 2.72M
Free Cash Flow
-7.44M -4.52M -4.14M